All Curated Mutation Sites in TBEV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in TBEV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
E
  
NS1
  
NS3
  
NS4B
  
NS5
  
C
  

Keyword: Encephalitis, tick-borne-24740396
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 24740396 Q32R
C
capsid
Encephalitis, tick-borne
G
R
L
View
2 24740396 K69R
C
capsid
Encephalitis, tick-borne
G
R
L
View
3 24740396 D100N
C
capsid
Encephalitis, tick-borne
G
R
L
View
4 24740396 111del
C
capsid
Encephalitis, tick-borne
G
R
L
View
5 24740396 S141G
NS1
NS1
Encephalitis, tick-borne
G
R
L
View
6 24740396 F108V
NS2B
NS2B
Encephalitis, tick-borne
G
R
L
View
7 24740396 R16K
NS3
NS3
Encephalitis, tick-borne
G
R
L
View
8 24740396 S45F
NS3
NS3
Encephalitis, tick-borne
G
R
L
View
9 24740396 M95V
NS4B
NS4B
Encephalitis, tick-borne
G
R
L
View
10 24740396 V179A
NS4B
NS4B
Encephalitis, tick-borne
G
R
L
View
11 24740396 A213V
NS4B
NS4B
Encephalitis, tick-borne
G
R
L
View
12 24740396 S634T
NS5
NS5
Encephalitis, tick-borne
G
R
L
View
13 24740396 R677K
NS5
NS5
Encephalitis, tick-borne
G
R
L
View
14 24740396 I692V
NS5
NS5
Encephalitis, tick-borne
G
R
L
View
15 24740396 A724S
NS5
NS5
Encephalitis, tick-borne
G
R
L
View
16 24740396 A151V
prM
prM
Encephalitis, tick-borne
G
R
L
View
Contents
Description

The table shows all curated mutation sites of TBEV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.